Atlas has been around for an estimated four to five years, and has Chet Sutterlin, M.D. as head of the Medical Advisory Board. Dr. Sutterlin has always brought a realistic approach to spine. Recently, the company enlisted Alan Olsen of Sofamor Danek fame to head up the companies search for additional capital. The word on the street is that Atlas has some interesting IP for anterior and posterior fixation. Though I have never seen it, I must take the word of our knowledgeable sources. The Spine Blogger would estimate that this company is generating $4-$6 million in revenues per annum. Like most early-growth stage companies, the Spine Blogger believes that Atlas is at a crossroads, in search of additional capital to take it to the next level. Their initial product the Verteview seemed to attract some attention, yet, by our analysis, this company needs cash to execute its strategic objective.
The Greek mythology character Atlas, was immortal and could not die, having to carry the weight of the world on its shoulders, the question is will Atlas be able to support itself? The Spine Blogger wants to know what its readers think?